Thomas Jefferson University

Julie Barta

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentPulmonary Diseases
Address800 Walnut Street
Philadelphia PA 19107
Phone215-955-5161
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Farjah F, Barta JA, Wood DE, Rivera MP, Osarogiagbon RU, Smith RA, Mullett TW, Rosenthal LS, Henderson LM, Detterbeck FC, Silvestri GA. The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline-concordant lung cancer staging. Cancer. 2024 Sep 30. PMID: 39347610.
      Citations:    
    2. Barta JA, Farjah F, Thomson CC, Dyer DS, Wiener RS, Slatore CG, Smith-Bindman R, Rosenthal LS, Silvestri GA, Smith RA, Gould MK. The American Cancer Society National Lung Cancer Roundtable strategic plan: Optimizing strategies for lung nodule evaluation and management. Cancer. 2024 Sep 30. PMID: 39347601.
      Citations:    
    3. Barta JA, Mazzone PJ, Nair VS. Multi-Cancer and Single-Cancer Early Detection Testing: Opportunities and Challenges. Chest. 2024 Sep; 166(3):425-428. PMID: 39260945.
      Citations:    
    4. Shusted CS, Eberth JM, Juon HS, Barta JA. Characteristics associated with early vs. late adoption of lung cancer screening. Prev Med Rep. 2024 Aug; 44:102820. PMID: 39099771.
      Citations:    
    5. Rshaidat H, Meredith L, Woodroof J, Aikhionbare I, Koeneman SH, Shusted C, Ruane B, Barta J, Okusanya OT. Incidence and Management of Cardiothoracic Relevant Extrapulmonary Findings Found on Low-Dose Computed Tomography. Ann Thorac Surg. 2024 May 28. PMID: 38815847.
      Citations:    
    6. Martin JF, Kane GC, Shusted CS, Barta JA. Implementation of High-Quality Lung Cancer Screening: Impact of Centralized vs. Decentralized Processes. Popul Health Manag. 2024 May 15. PMID: 38747169.
      Citations:    
    7. Till BM, Grenda T, Tidwell T, Wickes B, Shusted C, Ruane B, Okusanya O, Evans NR, Barta JA. Brief Report: Nonmalignant Surgical?Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules. Clin Lung Cancer. 2023 Dec 19. PMID: 38185612.
      Citations:    
    8. Shusted CS, Juon HS, Ruane B, Till B, Zeigler-Johnson C, McIntire RK, Grenda T, Okusanya O, Evans NR, Kane GC, Barta JA. Individual- and neighborhood-level characteristics of lung cancer screening participants undergoing telemedicine shared decision making. BMC Health Serv Res. 2023 Oct 30; 23(1):1179. PMID: 37899430.
      Citations:    
    9. Barta JA, Erkmen CP, Shusted CS, Myers RE, Saia C, Cohen S, Wainwright J, Zeigler-Johnson C, Dako F, Wender R, Kane GC, Vachani A, Rendle KA. The Philadelphia Lung Cancer Learning Community: A Multi-Health-System, Citywide Approach to Lung Cancer Screening. JNCI Cancer Spectr. 2023 Sep 15. PMID: 37713466.
      Citations:    
    10. Wen KY, Liang J, Diep D, Barta J, Juon HS. Smoking Cessation Interventions Among Asian Americans: a Scoping Review. J Racial Ethn Health Disparities. 2023 Aug 25. PMID: 37624538.
      Citations:    
    11. Shusted CS, Barta JA, Nguyen A, Wen KY, Juon HS, Zeigler-Johnson C. Characterizing Lung Cancer Burden Among Asian-American Communities in Philadelphia. J Racial Ethn Health Disparities. 2023 Aug 04. PMID: 37540304.
      Citations:    
    12. Ghassemi N, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Werner-Wasik M, Miller R, Barta JA, Grills I, Leiby BE, Guerrero T, Rusthoven CG, Vinogradskiy Y. Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial. Radiother Oncol. 2023 10; 187:109821. PMID: 37516361.
      Citations:    
    13. Daskalakis C, Shimada A, Myers RE, Eastburn K, DiCarlo MA, Shusted CS, Barta JA. Decision Preferences in Shared Decision-Making for Lung Cancer Screening Among White and African American Individuals. Ann Am Thorac Soc. 2023 Feb 24. PMID: 36827233.
      Citations:    
    14. Miller R, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Lu B, Werner-Wasik M, Ghassemi N, Lombardo J, Barta J, Grills I, Rusthoven CG, Guerrero T, Vinogradskiy Y. Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial. Adv Radiat Oncol. 2023 Mar-Apr; 8(2):101133. PMID: 36618762.
      Citations:    
    15. Huang CY, Mack S, Grenda TR, Barta JA, Till BM, Evans NR, Okusanya O. Race is a Risk Factor for the Deferral of Resection and Radiation for Early-Stage Lung Cancer. Clin Lung Cancer. 2022 11; 23(7):e460-e472. PMID: 35989162.
      Citations:    
    16. Zhao J, Barta JA, McIntire R, Shusted C, Zeigler-Johnson C, Juon HS. Racial difference in BMI and lung cancer diagnosis: analysis of the National Lung Screening Trial. BMC Cancer. 2022 Jul 19; 22(1):797. PMID: 35854273.
      Citations:    
    17. Russ DH, Barta JA, Evans NR, Stapp RT, Kane GC. Volume Doubling Time of Pulmonary Carcinoid Tumors Measured by Computed Tomography. Clin Lung Cancer. 2022 11; 23(7):e453-e459. PMID: 35922364.
      Citations:    
    18. Shusted CS, Evans NR, Kane GC, Juon HS, Barta JA. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021. JAMA Netw Open. 2022 Jun 01; 5(6):e2217578. PMID: 35704319.
      Citations:    
    19. DiCarlo M, Myers P, Daskalakis C, Shimada A, Hegarty S, Zeigler-Johnson C, Juon HS, Barta J, Myers RE. Outreach to primary care patients in lung cancer screening: A randomized controlled trial. Prev Med. 2022 Jun; 159:107069. PMID: 35469777.
      Citations:    
    20. Quinn ZL, Barta JA, Johnson JM. Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer care. Am J Med Sci. 2022 Apr 22. PMID: 35469765.
      Citations:    
    21. Kane GC, Barta JA, Shusted CS, Evans NR. Now Is the Time to Make Screening for Lung Cancer Reportable. Ann Intern Med. 2022 Apr 12. PMID: 35404673.
      Citations:    
    22. McIntire RK, Lewis E, Zeigler-Johnson C, Shusted C, Barta J, Juon HS, Keith SW, Klein G. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines. Popul Health Manag. 2022 04; 25(2):254-263. PMID: 35442796.
      Citations:    
    23. Majeed A, Ruane B, Shusted CS, Austin M, Mirzozoda K, Pimpinelli M, Vojnika J, Ward L, Sundaram B, Lakhani P, Kane G, Lev Y, Barta JA. Frequency of Statin Prescription Among Individuals with Coronary Artery Calcifications Detected Through Lung Cancer Screening. Am J Med Qual. 2022 Mar 17. PMID: 35302536.
      Citations:    
    24. Herskovitz E, Solomides C, Barta J, Evans N, Kane G. Detection of lung carcinoma arising from ground glass opacities (GGO) after 5 years - A retrospective review. Respir Med. 2022 05; 196:106803. PMID: 35305375.
      Citations:    
    25. Savitch SL, Zheng R, Abdelsattar ZM, Barta JA, Okusanya OT, Evans NR, Grenda TR. Surgical Outcomes in the National Lung Screening Trial Compared With Contemporary Practice. Ann Thorac Surg. 2022 Jan 07. PMID: 35007506.
      Citations:    
    26. Barta JA. Variation in Adherence to Lung Cancer Screening Among Vulnerable Populations. Chest. 2022 01; 161(1):16-17. PMID: 35000700.
      Citations:    
    27. Savitch SL, Grenda TR, Yi M, Till B, Mack S, Huang C, Barta JA, Evans NR, Okusanya OT. Facility-level national trends in racial disparities of surgical therapy for early-stage lung cancer. J Thorac Cardiovasc Surg. 2021 Dec 09. PMID: 35000683.
      Citations:    
    28. Barta JA, Shusted CS, Ruane B, Pimpinelli M, McIntire RK, Zeigler-Johnson C, Myers RE, Evans NR, Kane GC, Juon HS. Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence. Clin Lung Cancer. 2021 Jun 13. PMID: 34257020.
      Citations:    
    29. Shusted CS, Evans NR, Juon HS, Kane GC, Barta JA. Association of Race With Lung Cancer Risk Among Adults Undergoing Lung Cancer Screening. JAMA Netw Open. 2021 Apr 01; 4(4):e214509. PMID: 33822072.
      Citations:    
    30. Juon HS, Hong A, Pimpinelli M, Rojulpote M, McIntire R, Barta JA. Racial disparities in occupational risks and lung cancer incidence: Analysis of the National Lung Screening Trial. Prev Med. 2021 Feb; 143:106355. PMID: 33301822.
      Citations:    
    31. Lake M, Shusted CS, Juon HS, McIntire RK, Zeigler-Johnson C, Evans NR, Kane GC, Barta JA. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up. BMC Cancer. 2020 Jun 16; 20(1):561. PMID: 32546140.
      Citations:    
    32. Barta JA, Pauley K, Kossenkov AV, McMahon SB. The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer. Carcinogenesis. 2019 May 08. PMID: 31067569.
      Citations:    
    33. Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health. 2019 Jan 22; 85(1). PMID: 30741509.
      Citations:    
    34. Shusted CS, Barta JA, Lake M, Brawer R, Ruane B, Giamboy TE, Sundaram B, Evans NR, Myers RE, Kane GC. The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review. Popul Health Manag. 2018 Nov 08. PMID: 30407102.
      Citations:    
    35. Barta JA, McMahon SB. Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic Function. Mol Cancer Res. 2018 Sep 17. PMID: 30224539.
      Citations:    
    36. Barta JA, Zinner RG, Unger M. Lung Cancer in the Older Patient. Clin Geriatr Med. 2017 Nov; 33(4):563-577. PMID: 28991651.
      Citations:    
    37. Barta JA, Henschke CI, Flores RM, Yip R, Yankelevitz DF, Powell CA. Lung Cancer Diagnosis by Fine Needle Aspiration Is Associated With Reduction in Resection of Nonmalignant Lung Nodules. Ann Thorac Surg. 2017 Jun; 103(6):1795-1801. PMID: 28274517.
      Citations:    
    Barta's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (30)
    Explore
    _
    Co-Authors (26)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _